Daily Statin Cuts Cardiovascular Risk in HIV : comparemela.c

Final data from the REPRIEVE trial show pitavastatin therapy is associated with a significantly lower risk of cardiovascular events than placebo as evidence grows for statins in primary prevention.

Related Keywords

Thailand , Massachusetts , United States , Brisbane , Queensland , Australia , Boston , London , City Of , United Kingdom , Spain , South Africa , Brazil , Markella Zanni , Steven Grinspoon , Harvard Medical School , Society Conference , Mortimer Market Centre , Massachusetts General Hospital , Thenew England Journal , Medscape Medical , Atherosclerotic Cardiovascular Disease , South Asian , Laura Waters , Market Centre , Hiv Infection , Shiv , Lipids , Ipid Management , Statin , Lipid Lowering Drugs , Rug Lipid Lowering , Cv , Ardiovascular , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Cardiovascular Disease , Vd Cardiovascular Disease , Arteries , Hospitals , Infarct , Infarction , Stroke , Erebrovascular Accident , Va Cerebrovascular Accide ,